Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830178 · ClinicalTrials.gov registry record
A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 144,337
- Enrollment target
NCT02830178 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 144,337 participants.
The verdict
NCT02830178 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 144,337 participants
- Enrollment target
Study Summary
The Purpose of this study is to examine whether evidence of channeling exists by analyzing within a cohort of participants with first prescriptions of single-ingredient paracetamol or ibuprofen (or both) whether participants with paracetamol were more likely to have an ibuprofen-related contraindication.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144,337 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02830178
The ClinicalTrials.gov registry entry for NCT02830178 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144,337 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02830178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02830178 about?
NCT02830178 is a clinical study titled "A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications". The Purpose of this study is to examine whether evidence of channeling exists by analyzing within a cohort of participants with first prescriptions of single-ingredient paracetamol or ibuprofen (or both) whether participants with paracetamol were more likely to have an ibuprofen-related contraindica...
What is the current status of trial NCT02830178?
This trial is currently completed. The enrollment target is 144,337 participants. The study started on 2016-01. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT02830178?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.